Literature DB >> 7240301

Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.

D Brickley-Parsons, M J Glimcher, R J Smith, R Albin, J P Adams.   

Abstract

The palmar fascial tissues of more than 400 patients with Dupuytren's disease were studied biochemically and compared with normal tissue obtained from more than 100 patients who were undergoing hand surgery for other reasons. No alterations of the molecular structure or the state of macromolecular aggregation of the collagen in Dupuytren's disease were detected by wide or low-angle x-ray diffraction studies or by transmission electron microscopy. Major biochemical changes in the palmar fascia affected by Dupuytren's disease included increased collagen and hexosamine contents and the presence of galactosamine in the most severely involved tissue. Type-III collagen, which is virtually absent from normal adult palmar fascia, was abundant in the tissue of patients with Dupuytren's disease. Post-translational modifications included a very elevated hydroxylysine content, an increase in the total number of reducible cross-links, and the appearance of hydroxylysinohydroxynorleucine (virtually absent from normal palmar fascia) as the major reducible cross-link. Even palmar fascia from patients with Dupuytren's disease that appeared grossly and histologically normal showed the same biochemical changes, albeit to a lesser extent. All of these biochemical changes are similar to those that occur during the active stages of connective-tissue wound repair. This includes the rapid synthesis and turnover of collagen which leads to newly synthesized, immature collagen being more abundant in the involved tissue than in normal tissue. There is no evidence that the gross, macroscopic contracture of the palmar fascia in Dupuytren's disease is due to shortening, plication, or contraction of the collagen fibrils or fibers present in the tissue at the onset of the disease or synthesized during its development. Instead, we propose that the gross contracture (shortening) of the palmar fascia in Dupuytren's disease is due to an active cellular process that progressively draws the distal extremities of the affected tissue closer together at the same time that the original tissue is being replaced. The result of these two processes is simply a shorter, smaller piece of tissue fabric containing collagen molecules, fibrils, and fibers of normal length and organization, but with pretranslational and posttranslational modifications similar to those observed in collagens during the active stages of connective-tissue repair in general.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240301

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  32 in total

1.  Free radicals and Dupuytren's contracture.

Authors:  G A Murrell; M J Francis; L Bromley
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

2.  The Vikings and Baron Dupuytren's disease.

Authors:  A E Flatt
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

Review 3.  Dupuytren's contracture unfolded.

Authors:  W A Townley; R Baker; N Sheppard; A O Grobbelaar
Journal:  BMJ       Date:  2006-02-18

Review 4.  The fascia of the limbs and back--a review.

Authors:  Mike Benjamin
Journal:  J Anat       Date:  2009-01       Impact factor: 2.610

5.  Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions.

Authors:  Sofia Karkampouna; Peter Kloen; Miryam C Obdeijn; Scott M Riester; Andre J van Wijnen; Marianna Kruithof-de Julio
Journal:  J Vis Exp       Date:  2015-04-18       Impact factor: 1.355

6.  Dupuytren's contracture and gouty tophi in a black patient.

Authors:  I LeFlore; G A Antoine
Journal:  J Natl Med Assoc       Date:  1991-01       Impact factor: 1.798

7.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

8.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

9.  Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.

Authors:  Linda Vi; Lucy Feng; Rebecca D Zhu; Yan Wu; Latha Satish; Bing Siang Gan; David B O'Gorman
Journal:  Exp Cell Res       Date:  2009-07-18       Impact factor: 3.905

10.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.